Real‐world evidence on venetoclax in chronic lymphocytic leukemia ...

Real-world evidence on venetoclax in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia in the western world. In Italy, venetoclax was approved for use in patients ...

Three studies confirm the effectiveness and tolerability of this agent in patients with relapsed/refractory CLL and high-risk disease characteristics.

Real-world outcomes and management strategies for venetoclax ...

Venetoclax is a BCL2 inhibitor approved for 17p-deleted relapsed/refractory chronic lymphocytic leukemia with activity following kinase inhibitors.

Treatment Strategies Including Venetoclax Effective Against CLL in ...

Venetoclax (Venclexta) appears to be effective in both real-world data and clinical trials for patients with chronic lymphocytic leukemia (CLL).

Treatment Effectiveness with Venetoclax-Based Therapy after ...

The CLL Collaborative Study of Real-World Evidence (CORE), a ... Chronic Lymphocytic Leukemia: An International Real-World Study.

RWE on the Efficacy of Venetoclax-Based Regimens in CLL Match ...

Real-world evidence support the use of venetoclax-based regimens for patients with chronic lymphocytic leukemia based the consistent ...

Real-World Health Care Resource Use and Costs Among Patients ...

Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine ...

1908 Treatment Effectiveness with Venetoclax-Based Therapy after ...

... chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL). ... Methods: The CLL Collaborative Study of Real-World Evidence (CORE) ...

Real-world evidence of obinutuzumab and venetoclax in previously ...

Combinations of venetoclax (BCL2 inhibitor) plus an anti-CD20 antibody (obinutuzumab [Ven-O] or rituximab [Ven-R] are approved in chronic lymphocytic leukemia ...

Real-World Efficacy of Venetoclax-Based Regimens in Patients with ...

... chronic lymphocytic leukemia (CLL). Moreover, venetoclax-based ... venetoclax based therapy for CLL/small lymphocytic lymphoma (SLL).

Real-World Health Care Resource Use and Costs Among Patients ...

We compared all-cause and CLL-specific HRU and costs between patients initiated on B-cell lymphoma 2 inhibitor (venetoclax)– or Bruton tyrosine kinase ...

CLL-144 Real-World Healthcare Costs Among Patients With ...

CLL-144 Real-World Healthcare Costs Among Patients With Chronic Lymphocytic Leukemia Receiving First-Line Treatment With Venetoclax + Obinutuzumab Versus Bruton ...

Treatment Effectiveness with Venetoclax-Based Therapy after ...

... Chronic Lymphocytic Leukemia: An International Real-World Study ... Methods: The CLL Collaborative Study of Real-World Evidence (CORE), a ...

Paper: Real-World Comparison of Healthcare Costs of Venetoclax ...

Btki Use Among Elderly U.S. Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Front-Line (1L) Setting. Program: Oral and Poster ...

Real-world evidence of obinutuzumab and venetoclax in previously ...

... venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma ... world study to evaluate Ven-O in r/r CLL/SLL.

Real‐world evidence on venetoclax in chronic lymphocytic leukemia

Overall, the responses and tolerance to venetoclax observed in the Italian real‐world setting confirm the tolerability and effectiveness of venetClax ...

Real-World Study Confirms Efficacy of Venetoclax Alone, After BTKi ...

Venetoclax-based therapy is an effective treatment option for both patients with chronic lymphocytic leukemia/small lymphocytic leukemia ...

Implications of Real-World Data in the 1L Treatment of High-Risk CLL

Catherine C. Coombs, MD, discusses the value of real-world data in informing the treatment of patients with chronic lymphocytic leukemia.

Venetoclax Effectiveness, Safety, and Treatment Patterns in Chronic ...

... CLL pts treated in clinical practice. Methods: The CLL Collaborative Study of Real-World Evidence (CORE), a large multicenter chart review ...

Real-World Evidence on the Clinical Characteristics and ... - MDPI

The SRealCLL study aimed to obtain real-world evidence on the clinical characteristics and treatment patterns of patients with chronic lymphocytic leukemia ...